Letter: Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply

Kuo Cheng Wu; I. Cheng Lee

doi:10.1111/apt.18381

Letter: Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply

Kuo Cheng Wu, I. Cheng Lee^*

^*此作品的通信作者

醫學系內科學科

研究成果: Letter › 同行評審

原文	English
頁（從 - 到）	232-233
頁數	2
期刊	Alimentary Pharmacology and Therapeutics
卷	61
發行號	1
DOIs	https://doi.org/10.1111/apt.18381
出版狀態	Published - 1月 2025

存取文件

10.1111/apt.18381

其它文件與鏈接

Link to publication in Scopus

引用此

@article{bcc3b9ac63bb4fa380a380aa4b63de1c,

title = "Letter: Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply",

author = "Wu, {Kuo Cheng} and Lee, {I. Cheng}",

year = "2025",

month = jan,

doi = "10.1111/apt.18381",

language = "English",

volume = "61",

pages = "232--233",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Letter

T2 - Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Authors' Reply

AU - Wu, Kuo Cheng

AU - Lee, I. Cheng

PY - 2025/1

Y1 - 2025/1

UR - http://www.scopus.com/inward/record.url?scp=85208418480&partnerID=8YFLogxK

U2 - 10.1111/apt.18381

DO - 10.1111/apt.18381

M3 - Letter

C2 - 39501818

AN - SCOPUS:85208418480

SN - 0269-2813

VL - 61

SP - 232

EP - 233

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 1

ER -